Genomtec SA

WAR:GMT (Poland)  
zł 12.50 (-2.8%) Apr 26
At Loss
P/B:
14.03
Market Cap:
zł 147.44M ($ 36.58M)
Enterprise V:
zł 142.78M ($ 35.43M)
Volume:
39.41K
Avg Vol (2M):
37.34K
Warning! GuruFocus detected 5 Severe warning signs with GMT. Try a 7-Day Free Trial to check it out.
Also Trade In:
Volume:
39.41K
Market Cap zł:
147.44M
Market Cap $:
36.58M
At Loss
Avg Vol (2M):
37.34K
Enterprise Value zł:
142.78M
Enterprise Value $:
35.43M
PB Ratio:
14.03
Alerts Website Sources Stock PDF
Dataset
Financial Download Manual of Stocksâ„¢

Business Description

Genomtec SA

ISIN : PLGNMTC00017
http://www.genomtec.com
ul. Stab?owicka 147, PORT Building 2, Wroclaw, POL, 54-066
Compare
Compare
WAR:SDSWAR:ICEWAR:INMWAR:CMIWAR:NSTWAR:MDGWAR:GMZWAR:ADVWAR:MTNWAR:MSMABTSYKMDTBSXSZSE:300760EWDXCMZBHSTEXAMS:PHIA
Traded in other countries / regions
GMT.Poland4VI.Germany
IPO Date
2021-03-17
Description
Genomtec SA is an innovative technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.

Financial Strength

5/10
Name Current Vs Industry Vs History
Cash-To-Debt 3.21
Equity-to-Asset 0.54
Debt-to-Equity 0.2
Debt-to-EBITDA -0.17
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.44
Distress
Grey
Safe
Beneish M-Score 107.78
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -40.5
3-Year EBITDA Growth Rate -86
3-Year EPS without NRI Growth Rate -85.2
3-Year FCF Growth Rate -29
3-Year Book Growth Rate 57.3

Momentum Rank

8/10
Name Current Vs Industry Vs History
5-Day RSI 32.81
9-Day RSI 44.29
14-Day RSI 50.31
6-1 Month Momentum % -17.5
12-1 Month Momentum % 30.07

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.07
Quick Ratio 4.05
Cash Ratio 2.92
Days Inventory 13.78
Days Sales Outstanding 22426.37
Days Payable 189.32

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4.7
Shareholder Yield % -8.72

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % -12973.68
Operating Margin % -69868.42
Net Margin % -70252.63
FCF Margin % -60363.16
ROE % -196.44
ROA % -92.68
ROIC % -148.8
ROC (Joel Greenblatt) % -652.54
ROCE % -108.76

GF Value Rank

1/10
Name Current Vs Industry Vs History
PS Ratio 4166.67
PB Ratio 14.03
Price-to-Tangible-Book 62.5
EV-to-EBIT -10.95
EV-to-EBITDA -11.41
EV-to-Revenue 7514.79
EV-to-FCF -12.45
Price-to-Net-Current-Asset-Value 250
Earnings Yield (Greenblatt) % -9.13
FCF Yield % -7.78

Financials

WAR:GMT's 30-Y Financials
AAPL
Income Statement Breakdown
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Genomtec SA Executives

Details

GF Value: zł1.01

WAR:GMT

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil zł) 0.019
EPS (TTM) (zł) -1.27
Beta -0.41
Volatility % 40.53
14-Day RSI 50.31
14-Day ATR (zł) 0.82083
20-Day SMA (zł) 12.805
12-1 Month Momentum % 30.07
52-Week Range (zł) 8.14 - 14.4
Shares Outstanding (Mil) 11.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Genomtec SA Filings

Filing Date Document Date Form
No Filing Data

Genomtec SA Stock Events

Financials Calendars
Event Date Price(zł)
No Event Data

Genomtec SA Frequently Asked Questions

What is Genomtec SA(WAR:GMT)'s stock price today?
The current price of WAR:GMT is zł12.50. The 52 week high of WAR:GMT is zł14.40 and 52 week low is zł8.14.
When is next earnings date of Genomtec SA(WAR:GMT)?
The next earnings date of Genomtec SA(WAR:GMT) is .
Does Genomtec SA(WAR:GMT) pay dividends? If so, how much?
Genomtec SA(WAR:GMT) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.